Skip to main content
Journal cover image

IL28B C/C GENOTYPE IS PREDICTIVE OF >= 1 LOG10 IU/ML REDUCTION IN PLASMA HCV RNA AFTER 4 WEEKS OF PEGINTERFERON (PEGIFN) AND RIBAVIRIN (RBV) THERAPY: IMPLICATIONS FOR THE USE OF THE LEAD-IN STRATEGY FOR DIRECT-ACTING ANTIVIRAL-BASED TREATMENT REGIMENS

Publication ,  Conference
Thompson, AJ; Clark, PJ; Tillmann, HL; Patel, K; Naggie, S; Poordad, FF; Lawitz, E; Bacon, BR; Vierling, JM; Noviello, S; Brass, CA; Muir, AJ ...
Published in: HEPATOLOGY
October 1, 2011

Duke Scholars

Published In

HEPATOLOGY

ISSN

0270-9139

Publication Date

October 1, 2011

Volume

54

Start / End Page

436A / 437A

Location

San Francisco, CA

Publisher

WILEY-BLACKWELL

Conference Name

62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD)

Related Subject Headings

  • Gastroenterology & Hepatology
  • 3204 Immunology
  • 3202 Clinical sciences
  • 1107 Immunology
  • 1103 Clinical Sciences
  • 1101 Medical Biochemistry and Metabolomics
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Thompson, A. J., Clark, P. J., Tillmann, H. L., Patel, K., Naggie, S., Poordad, F. F., … Muir, A. J. (2011). IL28B C/C GENOTYPE IS PREDICTIVE OF >= 1 LOG10 IU/ML REDUCTION IN PLASMA HCV RNA AFTER 4 WEEKS OF PEGINTERFERON (PEGIFN) AND RIBAVIRIN (RBV) THERAPY: IMPLICATIONS FOR THE USE OF THE LEAD-IN STRATEGY FOR DIRECT-ACTING ANTIVIRAL-BASED TREATMENT REGIMENS. In HEPATOLOGY (Vol. 54, pp. 436A-437A). San Francisco, CA: WILEY-BLACKWELL.
Thompson, Alexander J., Paul J. Clark, Hans L. Tillmann, Keyur Patel, Susanna Naggie, F Fred Poordad, Eric Lawitz, et al. “IL28B C/C GENOTYPE IS PREDICTIVE OF >= 1 LOG10 IU/ML REDUCTION IN PLASMA HCV RNA AFTER 4 WEEKS OF PEGINTERFERON (PEGIFN) AND RIBAVIRIN (RBV) THERAPY: IMPLICATIONS FOR THE USE OF THE LEAD-IN STRATEGY FOR DIRECT-ACTING ANTIVIRAL-BASED TREATMENT REGIMENS.” In HEPATOLOGY, 54:436A-437A. WILEY-BLACKWELL, 2011.
Thompson AJ, Clark PJ, Tillmann HL, Patel K, Naggie S, Poordad FF, Lawitz E, Bacon BR, Vierling JM, Noviello S, Brass CA, Albrecht JK, Goldstein DB, McHutchison JG, Sulkowski MS, Muir AJ. IL28B C/C GENOTYPE IS PREDICTIVE OF >= 1 LOG10 IU/ML REDUCTION IN PLASMA HCV RNA AFTER 4 WEEKS OF PEGINTERFERON (PEGIFN) AND RIBAVIRIN (RBV) THERAPY: IMPLICATIONS FOR THE USE OF THE LEAD-IN STRATEGY FOR DIRECT-ACTING ANTIVIRAL-BASED TREATMENT REGIMENS. HEPATOLOGY. WILEY-BLACKWELL; 2011. p. 436A-437A.
Journal cover image

Published In

HEPATOLOGY

ISSN

0270-9139

Publication Date

October 1, 2011

Volume

54

Start / End Page

436A / 437A

Location

San Francisco, CA

Publisher

WILEY-BLACKWELL

Conference Name

62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD)

Related Subject Headings

  • Gastroenterology & Hepatology
  • 3204 Immunology
  • 3202 Clinical sciences
  • 1107 Immunology
  • 1103 Clinical Sciences
  • 1101 Medical Biochemistry and Metabolomics